Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

A Benard; A van Sighem; A Taieb; E Valadas; V Soriano; A Calmy; C Balotta; F Damond; F Brun-Vezinet; G Chene; S Matheron; The ACHIEV2E Collaboration Study Group

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

A Benard
, A van Sighem
, A Taieb
, E Valadas
, V Soriano
, A Calmy
, C Balotta
, F Damond
, F Brun-Vezinet
, G Chene
, S Matheron
, The ACHIEV2E Collaboration Study Group

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1257-1266
Number of pages	10
Journal	Clinical Infectious Diseases
Volume	52
Publication status	Published - 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-04-28-04
EMC MM-04-54-08-A

Cite this

Benard, A., van Sighem, A., Taieb, A., Valadas, E., Soriano, V., Calmy, A., Balotta, C., Damond, F., Brun-Vezinet, F., Chene, G., Matheron, S., & The ACHIEV2E Collaboration Study Group (2011). Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group. Clinical Infectious Diseases, 52, 1257-1266.

@article{ca899869ea564d6d8961e72730894d23,

title = "Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group",

author = "A Benard and \{van Sighem\}, A and A Taieb and E Valadas and V Soriano and A Calmy and C Balotta and F Damond and F Brun-Vezinet and G Chene and S Matheron and \{The ACHIEV2E Collaboration Study Group\}",

year = "2011",

language = "Undefined/Unknown",

volume = "52",

pages = "1257--1266",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

Benard, A, van Sighem, A, Taieb, A, Valadas, E, Soriano, V, Calmy, A, Balotta, C, Damond, F, Brun-Vezinet, F, Chene, G, Matheron, S & The ACHIEV2E Collaboration Study Group 2011, 'Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group', Clinical Infectious Diseases, vol. 52, pp. 1257-1266.

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group. / Benard, A; van Sighem, A; Taieb, A et al.
In: Clinical Infectious Diseases, Vol. 52, 2011, p. 1257-1266.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2 -infected patients: the ACHIEV2E Collaboration Study Group

AU - Benard, A

AU - van Sighem, A

AU - Taieb, A

AU - Valadas, E

AU - Soriano, V

AU - Calmy, A

AU - Balotta, C

AU - Damond, F

AU - Brun-Vezinet, F

AU - Chene, G

AU - Matheron, S

AU - The ACHIEV2E Collaboration Study Group, null

PY - 2011

Y1 - 2011

M3 - Article

SN - 1058-4838

VL - 52

SP - 1257

EP - 1266

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

ER -